182 related articles for article (PubMed ID: 22390538)
1. 3,5-Diaryl-2-aminopyridines as a novel class of orally active antimalarials demonstrating single dose cure in mice and clinical candidate potential.
Younis Y; Douelle F; Feng TS; González Cabrera D; Le Manach C; Nchinda AT; Duffy S; White KL; Shackleford DM; Morizzi J; Mannila J; Katneni K; Bhamidipati R; Zabiulla KM; Joseph JT; Bashyam S; Waterson D; Witty MJ; Hardick D; Wittlin S; Avery V; Charman SA; Chibale K
J Med Chem; 2012 Apr; 55(7):3479-87. PubMed ID: 22390538
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship studies of orally active antimalarial 3,5-substituted 2-aminopyridines.
González Cabrera D; Douelle F; Younis Y; Feng TS; Le Manach C; Nchinda AT; Street LJ; Scheurer C; Kamber J; White KL; Montagnat OD; Ryan E; Katneni K; Zabiulla KM; Joseph JT; Bashyam S; Waterson D; Witty MJ; Charman SA; Wittlin S; Chibale K
J Med Chem; 2012 Dec; 55(24):11022-30. PubMed ID: 23189922
[TBL] [Abstract][Full Text] [Related]
3. Novel orally active antimalarial thiazoles.
González Cabrera D; Douelle F; Feng TS; Nchinda AT; Younis Y; White KL; Wu Q; Ryan E; Burrows JN; Waterson D; Witty MJ; Wittlin S; Charman SA; Chibale K
J Med Chem; 2011 Nov; 54(21):7713-9. PubMed ID: 21966980
[TBL] [Abstract][Full Text] [Related]
4. 2,4-Diaminothienopyrimidines as orally active antimalarial agents.
González Cabrera D; Le Manach C; Douelle F; Younis Y; Feng TS; Paquet T; Nchinda AT; Street LJ; Taylor D; de Kock C; Wiesner L; Duffy S; White KL; Zabiulla KM; Sambandan Y; Bashyam S; Waterson D; Witty MJ; Charman SA; Avery VM; Wittlin S; Chibale K
J Med Chem; 2014 Feb; 57(3):1014-22. PubMed ID: 24446664
[TBL] [Abstract][Full Text] [Related]
5. Medicinal chemistry optimization of antiplasmodial imidazopyridazine hits from high throughput screening of a SoftFocus kinase library: part 1.
Le Manach C; Gonzàlez Cabrera D; Douelle F; Nchinda AT; Younis Y; Taylor D; Wiesner L; White KL; Ryan E; March C; Duffy S; Avery VM; Waterson D; Witty MJ; Wittlin S; Charman SA; Street LJ; Chibale K
J Med Chem; 2014 Mar; 57(6):2789-98. PubMed ID: 24568587
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity-relationship studies around the 2-amino group and pyridine core of antimalarial 3,5-diarylaminopyridines lead to a novel series of pyrazine analogues with oral in vivo activity.
Younis Y; Douelle F; González Cabrera D; Le Manach C; Nchinda AT; Paquet T; Street LJ; White KL; Zabiulla KM; Joseph JT; Bashyam S; Waterson D; Witty MJ; Wittlin S; Charman SA; Chibale K
J Med Chem; 2013 Nov; 56(21):8860-71. PubMed ID: 24099149
[TBL] [Abstract][Full Text] [Related]
7. Medicinal chemistry optimization of antiplasmodial imidazopyridazine hits from high throughput screening of a softfocus kinase library: part 2.
Le Manach C; Paquet T; Gonzàlez Cabrera D; Younis Y; Taylor D; Wiesner L; Lawrence N; Schwager S; Waterson D; Witty MJ; Wittlin S; Street LJ; Chibale K
J Med Chem; 2014 Nov; 57(21):8839-48. PubMed ID: 25313449
[TBL] [Abstract][Full Text] [Related]
8. Antimalarial pyrido[1,2-a]benzimidazoles.
Ndakala AJ; Gessner RK; Gitari PW; October N; White KL; Hudson A; Fakorede F; Shackleford DM; Kaiser M; Yeates C; Charman SA; Chibale K
J Med Chem; 2011 Jul; 54(13):4581-9. PubMed ID: 21644541
[TBL] [Abstract][Full Text] [Related]
9. Antiplasmodial activity, in vivo pharmacokinetics and anti-malarial efficacy evaluation of hydroxypyridinone hybrids in a mouse model.
Dambuza NS; Smith P; Evans A; Norman J; Taylor D; Andayi A; Egan T; Chibale K; Wiesner L
Malar J; 2015 Dec; 14():505. PubMed ID: 26671222
[TBL] [Abstract][Full Text] [Related]
10. Optimization of 4-aminoquinoline/clotrimazole-based hybrid antimalarials: further structure-activity relationships, in vivo studies, and preliminary toxicity profiling.
Gemma S; Camodeca C; Sanna Coccone S; Joshi BP; Bernetti M; Moretti V; Brogi S; Bonache de Marcos MC; Savini L; Taramelli D; Basilico N; Parapini S; Rottmann M; Brun R; Lamponi S; Caccia S; Guiso G; Summers RL; Martin RE; Saponara S; Gorelli B; Novellino E; Campiani G; Butini S
J Med Chem; 2012 Aug; 55(15):6948-67. PubMed ID: 22783984
[TBL] [Abstract][Full Text] [Related]
11. N-aryl-2-aminobenzimidazoles: novel, efficacious, antimalarial lead compounds.
Ramachandran S; Hameed P S; Srivastava A; Shanbhag G; Morayya S; Rautela N; Awasthy D; Kavanagh S; Bharath S; Reddy J; Panduga V; Prabhakar KR; Saralaya R; Nanduri R; Raichurkar A; Menasinakai S; Achar V; Jiménez-Díaz MB; Martínez MS; Angulo-Barturen I; Ferrer S; Sanz LM; Gamo FJ; Duffy S; Avery VM; Waterson D; Lee MC; Coburn-Flynn O; Fidock DA; Iyer PS; Narayanan S; Hosagrahara V; Sambandamurthy VK
J Med Chem; 2014 Aug; 57(15):6642-52. PubMed ID: 25007124
[TBL] [Abstract][Full Text] [Related]
12. 4-Aminoquinoline Antimalarials Containing a Benzylmethylpyridylmethylamine Group Are Active against Drug Resistant Plasmodium falciparum and Exhibit Oral Activity in Mice.
Joshi MC; Okombo J; Nsumiwa S; Ndove J; Taylor D; Wiesner L; Hunter R; Chibale K; Egan TJ
J Med Chem; 2017 Dec; 60(24):10245-10256. PubMed ID: 29185748
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of sulfonylurea derivatives as novel antimalarials.
León C; Rodrigues J; Gamboa de Domínguez N; Charris J; Gut J; Rosenthal PJ; Domínguez JN
Eur J Med Chem; 2007 Jun; 42(6):735-42. PubMed ID: 17321641
[TBL] [Abstract][Full Text] [Related]
14. Quinoline antimalarials containing a dibemethin group are active against chloroquinone-resistant Plasmodium falciparum and inhibit chloroquine transport via the P. falciparum chloroquine-resistance transporter (PfCRT).
Zishiri VK; Joshi MC; Hunter R; Chibale K; Smith PJ; Summers RL; Martin RE; Egan TJ
J Med Chem; 2011 Oct; 54(19):6956-68. PubMed ID: 21875063
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antimalarial activity in vitro and in vivo of a new ferrocene-chloroquine analogue.
Biot C; Glorian G; Maciejewski LA; Brocard JS
J Med Chem; 1997 Nov; 40(23):3715-8. PubMed ID: 9371235
[TBL] [Abstract][Full Text] [Related]
16. Antimalarial aminothiazoles and aminopyridines from phenotypic whole-cell screening of a SoftFocus(®) library.
Paquet T; Gordon R; Waterson D; Witty MJ; Chibale K
Future Med Chem; 2012 Dec; 4(18):2265-77. PubMed ID: 23234550
[TBL] [Abstract][Full Text] [Related]
17. A new class of phenazines with activity against a chloroquine resistant Plasmodium falciparum strain and antimicrobial activity.
Hussain H; Specht S; Sarite SR; Saeftel M; Hoerauf A; Schulz B; Krohn K
J Med Chem; 2011 Jul; 54(13):4913-7. PubMed ID: 21591758
[TBL] [Abstract][Full Text] [Related]
18. Antimalarial benzoheterocyclic 4-aminoquinolines: Structure-activity relationship, in vivo evaluation, mechanistic and bioactivation studies.
Ongarora DS; Strydom N; Wicht K; Njoroge M; Wiesner L; Egan TJ; Wittlin S; Jurva U; Masimirembwa CM; Chibale K
Bioorg Med Chem; 2015 Sep; 23(17):5419-32. PubMed ID: 26264839
[TBL] [Abstract][Full Text] [Related]
19. Structure-Activity Relationship Studies of Orally Active Antimalarial 2,4-Diamino-thienopyrimidines.
Gonzàlez Cabrera D; Douelle F; Le Manach C; Han Z; Paquet T; Taylor D; Njoroge M; Lawrence N; Wiesner L; Waterson D; Witty MJ; Wittlin S; Street LJ; Chibale K
J Med Chem; 2015 Sep; 58(18):7572-9. PubMed ID: 26322748
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antimalarial evaluation of a series of piperazinyl flavones.
Auffret G; Labaied M; Frappier F; Rasoanaivo P; Grellier P; Lewin G
Bioorg Med Chem Lett; 2007 Feb; 17(4):959-63. PubMed ID: 17166718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
